Direct medical costs of care for Chinese patients with colorectal neoplasia: a health care service provider perspective
Authors:
- Carlos K. H. WongCWCarlos K. H. Wong
- Cindy L. K. LamCLCindy L. K. Lam
- Jensen T. C. PoonJPJensen T. C. Poon
- Sarah M. McGheeSMSarah M. McGhee
- Wai‐Lun LawWLWai‐Lun Law
- Dora L. W. KwongDKDora L. W. Kwong
- Janice TsangJTJanice Tsang
- Pierre ChanPCPierre Chan
- 23 November 2011
- journal article
- research article
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 18 (6) , 1203-1210
Abstract
Objectives To estimate the direct medical cost of colorectal neoplasia (CRN) from newly diagnosed to the completion of the tumour‐specific treatment in the initial year of disease across stages and tumour primary sites.Methods Only direct medical costs from the perspective of the health care service provider were incorporated in the cost analysis (in 2009 USD) using a bottom‐up approach. Tumour‐specific treatments of surgery, chemotherapy and radiotherapy data in the initial year of disease were identified from the 401 CRN adult patients by a review of their medical records. Service utilization for diagnosis, staging, pre‐operative assessment and post‐operative follow‐up consultations was estimated from the recommendations of established surveillance and clinical practice guidelines.Results Direct medical cost for the care of a newly diagnosed CRN was ranging from $1941 for low‐risk polyp to $45 115 for stage IV colorectal cancer in the initial year of care. Costs of care showed a gradient increase from $1748 for low‐risk colonic polyps to $42 899 for stage IV colon cancer, and from $2232 for low‐risk rectal polyps to $48 453 for stage IV rectal cancers. Diagnostic/pre‐operative assessment and treatment accounted for most of total costs of colorectal polyp (58.9–76.7%) and cancer (60.8–85.2%) care.Conclusion The results provided stage and site‐specific estimations of the direct medical costs of CRN in a Chinese population that can assist policy decision making and facilitate health care service planning and cost‐effectiveness evaluations.Keywords
This publication has 16 references indexed in Scilit:
- Present Status and Perspectives of Colorectal Cancer in Asia: Colorectal Cancer Working Group Report in 30th Asia-Pacific Cancer ConferenceJapanese Journal of Clinical Oncology, 2010
- Trend of colorectal cancer in Hong Kong: 1983–2006Journal of Gastroenterology and Hepatology, 2010
- International Trends in Colorectal Cancer Incidence RatesCancer Epidemiology, Biomarkers & Prevention, 2009
- Estimating the cost related to surveillance of colorectal cancer in a French populationThe European Journal of Health Economics, 2009
- Cost‐effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in AsiaAlimentary Pharmacology & Therapeutics, 2008
- Cost of Care for Elderly Cancer Patients in the United StatesJNCI: Journal of the National Cancer Institute, 2008
- Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in FranceThe European Journal of Health Economics, 2007
- Projections of the costs associated with colorectal cancer care in the United States, 2000–2020Health Economics, 2007
- Hospital health care resource utilization and costs of colorectal cancer during the first 3‐year period following diagnosis in SwitzerlandAlimentary Pharmacology & Therapeutics, 2005
- Surveillance guidelines after removal of colorectal adenomatous polyps: Figure 1Gut, 2002